First oral COVID-19 treatments approved

Two drugs have been added to Australia’s arsenal in the fight against COVID-19, to treat people at increased risk of progression to hospitalisation or death The TGA has granted provisional approval of the first oral treatments for COVID-19 in Australia, MSD’s Lagevrio (molnupiravir) and Pfizer’s Paxlovid (nirmatrelvir + ritonavir). Both medicines are to be used

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous World news wrapup: 20 January 2022
Next Vax update: Novavax approved, Moderna increase, booster interval drop